On Sept. 11 and 12, nearly 100 researchers from the Ithaca Campus and the Weill Cornell Medicine Campus in New York City came together for the symposium, Metabolic Health: From Molecules to Populations.
The inaugural Flemmie Kittrell Visiting Scholar in the College of Human Ecology, Dr. Ruth C. Browne — president and CEO of Ronald McDonald House New York — will come to campus Oct. 4-6.
The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
A cross-college collaboration is opening new doors in the study of male infertility by breaking down a key step in sperm formation. Isolating the intricacies of meiotic sex chromosome inactivation, will now enable researchers to identify what happens when that key step fails.
A new project seeks to develop methodologies to assess food environments in two Kenyan cities, understand the role of informal vendors and offer guidance on how to measure the rapidly changing food environments.
An interdisciplinary Cornell research team has developed a new surgical technique that blocks the spread of focal epileptic seizures in the brain by making precise incisions with femtosecond laser pulses.
A team led by researchers at Weill Cornell Medicine has identified important drivers of the transformation of follicular lymphoma, a type of blood cancer, from a slow-growing form to the aggressive form it takes in some patients.
Tim Barry ’93 co-founded a health care company that offers primary care, multispecialty and urgent care options to 1.6 million patients throughout the U.S.
An American Heart Association Presidential Advisory, co-authored by Mario Herrero, professor in global development, calls for building on existing research and implementing cross-sector approaches to Food Is Medicine.
